Pharmaceuticals, Biotechnology and Life Sciences
WARREN, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) — Dr. Ryan Saadi, CEO of Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings…
Measure your biological age with cutting-edge epigenetic testing, 85% more affordable than competitors, bringing advanced longevity science within reach for…
Company will leverage recent financing and joint development agreement with electric aviation manufacturing partner to develop safer and more efficient…
Carlsbad, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) — Qualigen Therapeutics (NASDAQ: QLGN) (the “Company” or “Qualigen”) today announced that the…
Pooled data analysis of efficacy and safety from Phase 2b and Phase 3 data sets in patients with early-stage Parkinson’s…
Company Refocuses on Sycamore BioPharma, Navigates Challenges, and Prepares for Rebranding to Royal Enterprises, IncORLANDO, Fla., Dec. 05, 2024 (GLOBE…
CAMBRIDGE, Mass., Dec. 05, 2024 (GLOBE NEWSWIRE) — Alkeus Pharmaceuticals, Inc. today announced that results from its clinical studies of…
Approval of All Resolutions, Including Announced Transaction With Charme Capital PartnersCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 04, 2024…
Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomniaQUVIVIQ™ (daridorexant)…
Earlier this year FDA granted REVASCOR both Rare Pediatric Disease Designation (RPDD) and Orphan-Drug Designation (ODD) for congenital heart diseaseNEW…